Heparin cofactor II is a novel protective factor against carotid atherosclerosis in elderly individuals. - Wikidata - awgldk - TriplyDB

Heparin cofactor II is a novel protective factor against carotid atherosclerosis in elderly individuals.

Heparin cofactor II is a novel protective factor against carotid atherosclerosis in elderly individuals.

http://www.wikidata.org/entity/Q44899715

about

Protein z exerts pro-angiogenic effects and upregulates CXCR4 Strain-dependent embryonic lethality and exaggerated vascular remodeling in heparin cofactor II-deficient mice Placental dermatan sulfate: isolation, anticoagulant activity, and association with heparin cofactor II Ovarian cancer, the coagulation pathway, and inflammation Hemostasis and ageing.Androgen receptor counteracts Doxorubicin-induced cardiotoxicity in male mice Understanding Dermatan Sulfate-Heparin Cofactor II Interaction through Virtual Library Screening Heparin cofactor II, a serine protease inhibitor, promotes angiogenesis via activation of the AMP-activated protein kinase-endothelial nitric-oxide synthase signaling pathway.Is thrombin a key player in the 'coagulation-atherogenesis' maze?Fluorescent reporters of thrombin, heparin cofactor II, and heparin binding in a ternary complex.Hepatocytes respond differently to major dietary trans fatty acid isomers, elaidic acid and trans-vaccenic acid.Accelerated atherogenesis and neointima formation in heparin cofactor II deficient mice.Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II Serpins in thrombosis, hemostasis and fibrinolysis The association between A1C and subclinical cardiovascular disease: the multi-ethnic study of atherosclerosis.Heparin cofactor II in atherosclerotic lesions from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study.The heparin binding properties of heparin cofactor II suggest an antithrombin-like activation mechanism.Heparin Cofactor II: A Novel Plausible Link of Obesity and Diabetes with Thrombosis.The Role of Heparin Cofactor Ⅱ in the Regulation of Insulin Sensitivity and Maintenance of Glucose Homeostasis in Humans and Mice.High plasma aldosterone concentration is a novel risk factor of cognitive impairment in patients with hypertension.Plasma heparin cofactor II activity is inversely associated with left atrial volume and diastolic dysfunction in humans with cardiovascular risk factors.

P2860

Q21089651-1031EDD8-EF83-45CB-9943-3B92448A28CF Q24680458-FBC68002-6831-464F-9AA7-6EB30D82C080 Q24685941-234A1F30-8C10-44BC-9725-B0B1C40544C2 Q24816796-DE54F0C1-267A-48A9-8891-850E16E9BAC9 Q33378967-7BE7E28C-401D-45A9-8C0F-D698F5CC57C6 Q33637455-AEF20525-5277-41E9-BA5D-FC0DEB66344B Q33690582-56849EFB-40D6-4C43-A5F1-396A67A0D37D Q34384055-A633E5B2-0857-4112-8742-5491B2C5A3A6 Q34948467-3C0DB120-619B-4E8D-B420-3AEE88C92F82 Q36288526-A710769E-8804-473F-A4EF-253D701C7D7E Q36336243-20261658-10A8-4BB5-8A6B-C76EDE25C5A7 Q36447954-CB82A377-D9F7-4DD4-953D-25EE449C395B Q36528769-7CC796F2-267E-4DF3-BBCD-A5E9E3970EE9 Q36884340-C671ACCE-E290-4D45-9A5C-A11672877F14 Q37319210-6467B44F-0DFF-428C-BA3C-4826A6BAC888 Q37438938-AC2BBD5E-CD65-46DA-8E41-A53BEF09B993 Q45061724-EAC81F99-8798-4A78-A2CC-E727B31FE62C Q47135046-E072EB0E-26C5-481D-8995-14479BBC1A60 Q47142701-BCC68FAE-2DD0-4BBC-BC90-8D821AFE021F Q51837355-8AEC7206-3C13-4D0E-8DA3-128DF73A7A9B Q55053632-4885030A-B590-4E46-9AB5-BEF7D8848976

P2860

Heparin cofactor II is a novel protective factor against carotid atherosclerosis in elderly individuals.

http://www.wikidata.org/entity/Q44899715

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Heparin cofactor II is a novel ...... erosis in elderly individuals.

@en

Heparin cofactor II is a novel ...... erosis in elderly individuals.

@nl

type

label

Heparin cofactor II is a novel ...... erosis in elderly individuals.

@en

Heparin cofactor II is a novel ...... erosis in elderly individuals.

@nl

prefLabel

Heparin cofactor II is a novel ...... erosis in elderly individuals.

@en

Heparin cofactor II is a novel ...... erosis in elderly individuals.

@nl

P1433

Q44899715-D277E308-22B7-4802-9119-1BB6BA3F62E3

P1476

Q44899715-F15CA9EA-0DB0-41F4-BDEE-2D6A8021874C

P2093

Q44899715-28803B8C-B201-4ADD-82D2-76AD1E498A72

Q44899715-426B8E0A-FDC5-4B43-B55C-4D334504A56B

Q44899715-4FF9DEA9-1AF7-4094-963E-3EE068EBD5D0

Q44899715-5D895F3D-869B-4FFB-A944-FF692027403F

Q44899715-6C98A54B-061B-43BC-ADC7-A90BF94D9893

Q44899715-91E060CA-72C4-4464-8BA0-0FDD08DB0D56

Q44899715-946897C2-2A4C-4A8E-BBD3-FE74FB247589

Q44899715-AFF9CCC7-AD01-4A8E-BDE2-3C615E490A81

Q44899715-B116A1C7-E13E-447C-BA16-408E7D67ACC8

Q44899715-B17E9064-93E8-4395-B427-6222FC3BE3B6

P304

Q44899715-0951891E-8FD3-46F7-B526-F79B9299F484

P31

Q44899715-2A19A161-6B53-4697-A154-C9FBE655AE32

P356

Q44899715-6F37EA39-9DDF-46C5-945F-5BE5C54385E5

P407

Q44899715-22935025-CA4B-4592-8484-77B31562BA59

P433

Q44899715-944A064E-AB41-4947-BF14-599A3019C6FF

P478

Q44899715-73296924-0A6C-473C-B9FB-B3FAFF422365

P50

Q44899715-DC557107-F569-4AC2-B954-A0FF070E13DE

P577

Q44899715-D037F462-B3F1-477C-8CFF-B38A7C03B2A1

P698

Q44899715-0EA78141-22CE-4264-BE91-8CBDBF8F6B4D

P921

Q44899715-D5DF7736-B4EB-4870-B5ED-7DC037EE4323

P356

01.CIR.0000129968.46095.F3

P1433

P1476

Heparin cofactor II is a novel ...... erosis in elderly individuals.

@en

P2093

Akira Kondo

http://www.w3.org/2001/XMLSchema#string

Hiroshi Yamaguchi

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Azuma

http://www.w3.org/2001/XMLSchema#string

Masashi Akaike

http://www.w3.org/2001/XMLSchema#string

Midori Kato

http://www.w3.org/2001/XMLSchema#string

Mitsunori Fujimura

http://www.w3.org/2001/XMLSchema#string

Nobuyuki Takamori

http://www.w3.org/2001/XMLSchema#string

Shuji Kato

http://www.w3.org/2001/XMLSchema#string

Shunji Hashizume

http://www.w3.org/2001/XMLSchema#string

Tomoko Arase

http://www.w3.org/2001/XMLSchema#string

P304

2761-2765

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.CIR.0000129968.46095.F3

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Ken-ichi Aihara

P577

2004-05-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15148272

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis